COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,749 Articles (22,502 medRxiv, 8,247 bioRxiv)

Most recent first Previous |  Page 123: Articles 1221-1230  | Next

A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden
Bergstrom, F., Gunther, F., Britton, T.
10.1101/2024.08.22.24312361 — Posted: 2024-08-23
Unraveling the impact of COVID-19 on urban mobility: A Causal Machine Learning Analysis of Beijing's Subway System
Zou, L., Chen, Y., Guo, R., Wang, P., He, Y., Chen, S., Wang, Z., Zhu, J.
10.1101/2024.08.22.24312324 — Posted: 2024-08-23
Post-discharge health-related quality of life, cognitive function, disability, risk of post-traumatic stress disorder, and depression amongst the survivors of venovenous extracorporeal membrane oxygenation (VV-ECMO) during the COVID-19 pandemic: a nested cohort study protocol
Ursu, E., Mikolic, A., Thiara, S., Silverberg, N. D., Foster, D., Panenka, W., Parag, N., Sekhon, M. S., Griesdale, D. E. G.
10.1101/2024.08.22.24312450 — Posted: 2024-08-23
Bronchoalveolar Lavage Single-Cell Transcriptomics Identifies Immune Cells Driving COVID-19 Severity in Patients
Asaba, C. N., Bitazar, R., Labonte, P. N., Bukong, T. N.
10.1101/2024.08.22.609137 — Posted: 2024-08-23
Joint Impacts of Nutrition and Socioeconomic Status on SARS-CoV-2 Antibody Titer in a Prospective Birth Cohort in Brazil.
Vahora, M., Leao, O., Silveira, M. F., Domingues, M. R., Hallal, P., Kraay, A.
10.1101/2024.08.22.24312306 — Posted: 2024-08-22
Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19
Yan, H., Hu, S., Zhang, H., Zhou, Y., Fu, R., Xu, P., Cai, H., Li, X., Lan, G.
10.1101/2024.08.22.24312416 — Posted: 2024-08-22
Baseline drug treatments and long-term outcomes in COVID-19-hospitalized patients: results of the 2020 AUTCOV study
Graf, A. C., Reichardt, B., Wagenlechner, C., Krotka, P., Traxler-Weidenauer, D., Mildner, M., Mascherbauer, J., Aigner, C., Auer, J., Wendt, R., Ankersmit, H. J.
10.1101/2024.08.22.24312424 — Posted: 2024-08-22
Comparison of Peripheral Nerve Injury Outcomes Between COVID-19 Survivors and Non-COVID Rehabilitation Inpatients: A Retrospective Study
Mondriguez-Gonzalez, A., Rothemich, B. M., Sheth, M. N., Swong, K. N., Franz, C. K.
10.1101/2024.08.22.24312439 — Posted: 2024-08-22
Long-term monitoring of SARS-CoV-2 load and variant composition at a large metropolitan wastewater treatment plant using a simple two-step direct capture RNA extraction, droplet digital PCR, and targeted mutation assays
Balogh, S. J., Sprouse, G. B., Beckman, K. B., Watson, R. H. B., Johnson, D. M., Pinkerton, L. D., Nollet, Y. H., Sealock, A. W., Atkins, W. S. C., Selenke, L. M., Kinney, J. A., Grady, P. J. R., Vanderbush, B., Daniel, J. J.
10.1101/2024.08.21.24311866 — Posted: 2024-08-21
Severe disease is not essential for a high neutralizing antibody response post-SARS-CoV-2 infection
Khairallah, A., Jule, Z., Piller, A., Bernstein, M., Reedoy, K., Ganga, Y., Gosnell, B., Karim, F., Moosa, Y., Ndung'u, T., Khan, K., Sigal, A.
10.1101/2024.08.21.24312063 — Posted: 2024-08-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).